Reuters logo
Lundbeck says Northera available in U.S. after FDA approval
September 2, 2014 / 2:20 PM / 3 years ago

Lundbeck says Northera available in U.S. after FDA approval

COPENHAGEN (Reuters) - Lundbeck said on Tuesday its drug used to treat disorders caused by an underlying neurological disease had been approved by the U.S. Food and Drug Administration and the capsules are available to the country’s market through specialty pharmacies.

Northera is only approved for use in the United States and treats patients who complain of dizziness caused by neurological diseases such as Parkinson‘s, the company said.

Reporting by Sabina Zawadzki

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below